In November 2011, FCC Commissioners unanimously agreed to allocate spectrum and adopt service and technical rules for the utilization of new implanted medical devices that operate on 413-457 MHz (70 cm). These devices will be used on a secondary basis as part of the Medical Device Radiocommunication (MedRadio) Service in Part 95 of the FCC rules. In the Federal Register for Friday, January 27, the FCC announced that the effective date for these new rules is Monday, February 27. The new rules expand the existing MedRadio Service rules to permit the use of new wideband medical implant devices that employ neuromuscular microstimulation techniques to restore sensation, mobility, and other functions to paralyzed limbs and organs. These medical devices hold enormous promise to advance the state of medical care, lower health costs, and improve the quality of life for countless Americans. The rules will allow these new types of MedRadio devices to access 24 megahertz of spectrum in the 413–419 MHz, 426–432 MHz, 438–444 MHz, and 451–457 MHz bands on a secondary basis.